English

Insider transactions

EDGAR

Celularity Inc

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-15.

Open-market purchases (code P): 0 transactions, — shares
Open-market sales (code S): 0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 53

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
Date	Reporting owner	Code	Acquired or disposed	Shares	Price per share, as filed	Value (derived)	Shares owned after	Direct or indirect	Rule 10b5-1 box	Notes	Source
2026-09-23 Filed 2026-09-25	Barach Philip Alan Director · 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,000,000) — exercise price 1.50	Acquired (A)	192,771	—	—	2,000,000	Indirect (I) See Footnote	No	F1, F2 F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111026 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Philip Alan Director · 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,140,000) — exercise price 1.50	Acquired (A)	2,140,000	—	—	2,140,000	Indirect (I) See Footnote	No	F4, F2 F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111026 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Philip Alan Director · 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,177,000) — exercise price 1.50	Acquired (A)	1,177,000	—	—	1,177,000	Indirect (I) See Footnote	No	F5, F4, F2 F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants. F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111026 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Philip Alan Director · 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Indirect (I) See Footnote	No	F6, F2 F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111026 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Philip Alan Director · 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Indirect (I) See Footnote	No	F7, F6, F2 F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111026 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,000,000) — exercise price 1.50	Acquired (A)	192,771	—	—	2,000,000	Indirect (I) See Footnote	No	F1, F2 F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111027 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,140,000) — exercise price 1.50	Acquired (A)	2,140,000	—	—	2,140,000	Indirect (I) See Footnote	No	F4, F2 F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111027 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,177,000) — exercise price 1.50	Acquired (A)	1,177,000	—	—	1,177,000	Indirect (I) See Footnote	No	F5, F4, F2 F5 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants. F4 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111027 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Indirect (I) See Footnote	No	F6, F2 F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111027 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Indirect (I) See Footnote	No	F7, F6, F2 F7 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F6 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F2 The Philip and Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-111027 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,000,000) — exercise price 1.50	Acquired (A)	192,771	—	—	2,000,000	Direct (D)	No	F1 F1 Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.	Open filing 0001104659-26-111028 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (2,140,000) — exercise price 1.50	Acquired (A)	2,140,000	—	—	2,140,000	Direct (D)	No	F3 F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.	Open filing 0001104659-26-111028 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,177,000) — exercise price 1.50	Acquired (A)	1,177,000	—	—	1,177,000	Direct (D)	No	F4, F3 F4 Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants. F3 Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the September 2026 Notes) that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.	Open filing 0001104659-26-111028 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Direct (D)	No	F5 F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.	Open filing 0001104659-26-111028 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (1,457,765) — exercise price 2.00	Acquired (A)	1,457,765	—	—	1,457,765	Direct (D)	No	F6, F5 F6 Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid. F5 Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the September 2027 Notes) that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.	Open filing 0001104659-26-111028 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,204,819) — exercise price 1.66	Disposed (D)	1,204,819	—	—	0	Indirect (I) See Footnote	No	F1, F3 F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration. F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-076681 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Barach Daniele Wolf 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (839,160) — exercise price 2.00	Disposed (D)	839,160	—	—	0	Indirect (I) See Footnote	No	F2, F1, F3 F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date. F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration. F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-076681 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,204,819) — exercise price 1.66	Disposed (D)	1,204,819	—	—	0	Direct (D)	No	F1 F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.	Open filing 0001104659-26-076683 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Philip Daniele Barach Family Trust 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (839,160) — exercise price 2.00	Disposed (D)	839,160	—	—	0	Direct (D)	No	F2, F1 F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date. F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration.	Open filing 0001104659-26-076683 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Barach Philip Alan 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Convertible Notes — underlying Class A Common Stock (1,204,819) — exercise price 1.66	Disposed (D)	1,204,819	—	—	0	Indirect (I) See Footnote	No	F1, F3 F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration. F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-076682 Read from the filing’s XML Dispute this row
2026-06-19 Filed 2026-06-23	Barach Philip Alan 10% owner	J Other acquisition or disposition (describe transaction) Derivative security: Warrants — underlying Class A Common Stock (839,160) — exercise price 2.00	Disposed (D)	839,160	—	—	0	Indirect (I) See Footnote	No	F2, F1, F3 F2 Represented shares of Class A Common Stock issuable upon the exercise of up to 839,160 warrants (the Warrants) that the Reporting Person had the option to obtain from the Issuer in connection with the purchase by the Reporting Person of the Notes at any time until June 19, 2026. Because the Reporting Person's option to purchase the Notes expired pursuant to its terms on June 19, 2026, the ability to obtain such Warrants also expired on such date. F1 Represented shares of Class A Common Stock issuable upon the conversion of up to $2,000,000 in aggregate principal amount of convertible notes (the Notes) that the Reporting Person had the option to purchase from the Issuer at any time until June 19, 2026. The option to purchase such Notes expired pursuant to its terms on June 19, 2026, and no consideration was paid in connection with such expiration. F3 The Philip Daniele Barach Family Trust (the Trust) is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein.	Open filing 0001104659-26-076682 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Hariri Robert J Director · Officer: Chief Executive Officer	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock	Acquired (A)	3,281	0	—	2,854,735	Direct (D)	No	F1 F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.	Open filing 0001493152-26-016832 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Hariri Robert J Director · Officer: Chief Executive Officer	F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock	Disposed (D)	1,182	1.28	1,512.96 Derived: shares × price per share. Exact value 1512.96.	2,853,553	Direct (D)	No	F2 F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.	Open filing 0001493152-26-016832 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Hariri Robert J Director · Officer: Chief Executive Officer	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Derivative security: Restricted Stock Units — underlying Class A Common Stock (3,281)	Disposed (D)	3,281	0	—	0	Direct (D)	No	F3, F4 F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. F4 On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.	Open filing 0001493152-26-016832 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Haines John R Officer: Senior Exec Vice President	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock	Acquired (A)	1,641	0	—	30,762	Direct (D)	No	F1 F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A common stock. On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.	Open filing 0001493152-26-016833 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Haines John R Officer: Senior Exec Vice President	F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock	Disposed (D)	583	1.28	746.24 Derived: shares × price per share. Exact value 746.24.	30,179	Direct (D)	No	F2 F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.	Open filing 0001493152-26-016833 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Haines John R Officer: Senior Exec Vice President	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Derivative security: Restricted Stock Units — underlying Class A Common Stock (1,641)	Disposed (D)	1,641	0	—	0	Direct (D)	No	F3, F4 F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. F4 On April 13, 2022, the reporting person was granted 6,562 RSUs, 25% of which vested on April 13, 2026. The Class a common stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.	Open filing 0001493152-26-016833 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Brigido Stephen Officer: Pres., Functional Regeneration	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Class A Common Stock	Acquired (A)	821	0	—	9,742	Direct (D)	No	F1 F1 Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.	Open filing 0001493152-26-016834 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Brigido Stephen Officer: Pres., Functional Regeneration	F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Class A Common Stock	Disposed (D)	268	1.28	343.04 Derived: shares × price per share. Exact value 343.04.	9,474	Direct (D)	No	F2 F2 This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.	Open filing 0001493152-26-016834 Read from the filing’s XML Dispute this row
2026-04-13 Filed 2026-04-15	Brigido Stephen Officer: Pres., Functional Regeneration	M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Derivative security: Restricted Stock Units — underlying Class A Common Stock (821)	Disposed (D)	821	0	—	0	Direct (D)	No	F3, F4 F3 Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. F4 On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.	Open filing 0001493152-26-016834 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15	Ling Geoffrey M.D. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	19,231	0.00	0 Derived: shares × price per share. Exact value 0.00.	256,026	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.	Open filing 0001493152-26-002424 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15	Parks Diane L. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	30,000	0.00	0 Derived: shares × price per share. Exact value 0.00.	520,021	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.	Open filing 0001493152-26-002427 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15	LeVien Vincent Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	28,847	0.00	0 Derived: shares × price per share. Exact value 0.00.	153,847	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.	Open filing 0001493152-26-002423 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-15	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	20,385	0.00	0 Derived: shares × price per share. Exact value 0.00.	394,150	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.	Open filing 0001493152-26-002425 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14	Parks Diane L. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	30,000	0	—	520,021	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 30,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-26-002297 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14	LeVien Vincent Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	28,847	0	—	153,847	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-26-002300 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	20,385	0	—	394,150	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 20,385 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-26-002298 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14	Ling Geoffrey M.D. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	19,231	0.00	0 Derived: shares × price per share. Exact value 0.00.	256,026	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-26-002303 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Parks Diane L. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	125,000	0.00	0 Derived: shares × price per share. Exact value 0.00.	490,021	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029615 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Parks Diane L. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Derivative security: Stock Options — underlying Class A Common Stock (156,250) — exercise price 1.20	Acquired (A)	156,250	0	—	518,774	Direct (D)	No	F3 F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029615 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	125,000	0.00	0 Derived: shares × price per share. Exact value 0.00.	373,765	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029614 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Derivative security: Stock Options — underlying Class A Common Stock (156,250) — exercise price 1.20	Acquired (A)	156,250	0	—	518,774	Direct (D)	No	F3 F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029614 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	LeVien Vincent Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	125,000	0.00	0 Derived: shares × price per share. Exact value 0.00.	125,000	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029618 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	LeVien Vincent Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Derivative security: Stock Options — underlying Class A Common Stock (156,250) — exercise price 1.20	Acquired (A)	156,250	0	—	156,250	Direct (D)	No	F3 F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029618 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Ling Geoffrey M.D. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	125,000	0.00	0 Derived: shares × price per share. Exact value 0.00.	236,795	Direct (D)	No	F1, F2 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029617 Read from the filing’s XML Dispute this row
2025-12-29 Filed 2025-12-30	Ling Geoffrey M.D. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Derivative security: Stock Options — underlying Class A Common Stock (156,250) — exercise price 1.20	Acquired (A)	156,250	0	—	1,490,996	Direct (D)	No	F3 F3 This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.	Open filing 0001493152-25-029617 Read from the filing’s XML Dispute this row
2025-12-19 Filed 2025-12-22	Ling Geoffrey M.D. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	67,416	0.00	0 Derived: shares × price per share. Exact value 0.00.	111,795	Direct (D)	No	F1 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.	Open filing 0001493152-25-028780 Read from the filing’s XML Dispute this row
2025-12-19 Filed 2025-12-22	Parks Diane L. Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	67,416	0.00	0 Derived: shares × price per share. Exact value 0.00.	365,021	Direct (D)	No	F1 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested and became exercisable on December 19, 2025.	Open filing 0001493152-25-028787 Read from the filing’s XML Dispute this row
2025-12-19 Filed 2025-12-22	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	67,416	0.00	0 Derived: shares × price per share. Exact value 0.00.	248,765	Direct (D)	No	F1 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vested on December 19, 2025.	Open filing 0001493152-25-028778 Read from the filing’s XML Dispute this row
2025-11-19 Filed 2025-11-21	Diamandis Peter Director	A Grant, award or other acquisition pursuant to Rule 16b-3(d) Class A Common Stock	Acquired (A)	47,042	0.00	0 Derived: shares × price per share. Exact value 0.00.	248,765	Direct (D)	No	F1 F1 These shares represent restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan (the 2021 Plan), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant.	Open filing 0001493152-25-024630 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 6,317 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,141 filings read.

Showing 1–25 of 25

Institutional holders, largest position first, as filed
Manager	Shares or principal	Value as filed	Change from the prior quarter	Source
C V STARR CO INC	764,069 SH	1,031,494 dollars	Unchanged Prior quarter: 764,069	Open filing 0001140361-26-043078 Filed 2026-11-10 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager	167,150 SH	225,697 dollars	Unchanged Prior quarter: 167,150	Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
UBS Group AG Partly reported under another manager	80,075 SH	108,101 dollars	Higher by 73,117 Prior quarter: 6,958	Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
STATE STREET CORP Partly reported under another manager	57,830 SH	78,071 dollars	Unchanged Prior quarter: 57,830	Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Biltmore Family Office, LLC	35,000 SH	47,250 dollars	Unchanged Prior quarter: 35,000	Open filing 0001398344-26-019404 Filed 2026-11-03 Dispute this row
HB Wealth Management, LLC	31,915 SH	43,085 dollars	Unchanged Prior quarter: 31,915	Open filing 0001172661-26-004668 Filed 2026-10-23 Dispute this row
Sky Investment Group LLC	29,920 SH	40,392 dollars	Not in the prior quarter’s filings read	Open filing 0001941040-26-000786 Filed 2026-10-30 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager	17,403 SH	23,494 dollars	Lower by 11,310 Prior quarter: 28,713	Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
IPG Investment Advisors LLC	17,169 SH	23,178 dollars	Unchanged Prior quarter: 17,169	Open filing 0001602237-26-000008 Filed 2026-10-30 Dispute this row
GROUP ONE TRADING LLC Option: Call	9,700 SH	13,095 dollars	Not in the prior quarter’s filings read	Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
BFC Planning, Inc.	7,713 SH	10,413 dollars	Unchanged Prior quarter: 7,713	Open filing 0001420506-26-002645 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Call	6,000 SH	8,100 dollars	Not in the prior quarter’s filings read	Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
SBI Securities Co., Ltd.	1,882 SH	2,541 dollars	Lower by 402 Prior quarter: 2,284	Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
CALDWELL SUTTER CAPITAL, INC.	1,000 SH	1,350 dollars	Unchanged Prior quarter: 1,000	Open filing 0000702007-26-000013 Filed 2026-11-09 Dispute this row
CoreCap Advisors, LLC	500 SH	675 dollars	Unchanged Prior quarter: 500	Open filing 0001902501-26-000006 Filed 2026-10-08 Dispute this row
Global Retirement Partners, LLC	300 SH	405 dollars	Unchanged Prior quarter: 300	Open filing 0001580642-26-007620 Filed 2026-11-10 Dispute this row
Financial Perspectives, Inc	171 SH	231 dollars	Unchanged Prior quarter: 171	Open filing 0002003287-26-000005 Filed 2026-11-03 Dispute this row
VALLEY NATIONAL ADVISERS INC	100 SH	135 dollars	Unchanged Prior quarter: 100	Open filing 0000773411-26-000007 Filed 2026-10-23 Dispute this row
SIMPLEX TRADING, LLC Option: Put	100 SH	135 dollars	Not in the prior quarter’s filings read	Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager	99 SH	134 dollars	Unchanged Prior quarter: 99	Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
United Financial Planning Group LLC	19 SH	26 dollars	Unchanged Prior quarter: 19	Open filing 0002088337-26-000008 Filed 2026-11-04 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager	16 SH	22 dollars	Unchanged Prior quarter: 16	Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
HARBOUR INVESTMENTS, INC.	15 SH	20 dollars	Unchanged Prior quarter: 15	Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row
BARCLAYS PLC Partly reported under another manager	4 SH	5 dollars	Not in the prior quarter’s filings read	Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
DANSKE BANK A/S	1 SH	1 dollars	Unchanged Prior quarter: 1	Open filing 0001104659-26-124081 Filed 2026-11-09 Dispute this row

Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

Walleye Capital LLC 835,194 SH
VANGUARD CAPITAL MANAGEMENT LLC 621,105 SH
Linden Advisors LP 550,119 SH
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 350,000 SH
PEAK6 LLC 171,363 SH
Davidson Kempner Capital Management LP 150,800 SH
Context Capital Management, LLC 150,000 SH
CITADEL ADVISORS LLC 99,054 SH
Lombard Odier Asset Management (Europe) Ltd 84,919 SH
VANGUARD FIDUCIARY TRUST CO 79,874 SH
BlackRock, Inc. 76,359 SH
TWO SIGMA SECURITIES, LLC 65,609 SH
HRT FINANCIAL LP 56,591 SH
Corient Private Wealth LP 50,000 SH
NORTHERN TRUST CORP 44,163 SH
KEYNOTE FINANCIAL SERVICES LLC 29,920 SH
CenterStar Asset Management, LLC 21,000 SH
Virtu Financial LLC 18,697 SH
ROYAL BANK OF CANADA 18,000 SH
CenterStar Asset Management, LLC 15,000 SH
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,619 SH
IFP Advisors, Inc 12,000 SH
Clear Street Group Inc. 11,613 SH
Weaver Capital Management LLC 11,609 SH
Procyon Advisors, LLC 11,500 SH
Tower Research Capital LLC (TRC) 5,111 SH
GROUP ONE TRADING LLC 3,595 SH
WELLS FARGO COMPANY/MN 2,500 SH
Vanguard Global Advisers, LLC 2,315 SH
SIMPLEX TRADING, LLC 2,188 SH
HighMark Wealth Management LLC 441 SH
MERCER GLOBAL ADVISORS INC /ADV 100 SH
JONES FINANCIAL COMPANIES LLLP 82 SH
WOLVERINE ASSET MANAGEMENT LLC 68 SH
MORGAN STANLEY 21 SH
TORNO CAPITAL, LLC 1 SH

Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
A change is the difference between two quarter-end snapshots, not a trade.
A position reported under another manager may also appear in that manager’s filing; rows are not added together.
Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
Holder	Percent of class	Shares held	Event date	Form	Source
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share	29.0	11,940,187.00	09/23/2026 Filed 2026-09-28	SCHEDULE 13D/AAmendment 3	Open filing 0001104659-26-111279 Dispute this row
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share	29.0	11,940,187.00	09/23/2026 Filed 2026-09-28	SCHEDULE 13D/AAmendment 3	Open filing 0001104659-26-111279 Dispute this row
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share	29.0	11,940,187.00	09/23/2026 Filed 2026-09-28	SCHEDULE 13D/AAmendment 3	Open filing 0001104659-26-111279 Dispute this row
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share	15.8	5,514,686.00	06/19/2026 Filed 2026-06-23	SCHEDULE 13D/AAmendment 2	Open filing 0001104659-26-076580 Dispute this row
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share	15.8	5,514,686.00	06/19/2026 Filed 2026-06-23	SCHEDULE 13D/AAmendment 2	Open filing 0001104659-26-076580 Dispute this row
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share	15.8	5,514,686.00	06/19/2026 Filed 2026-06-23	SCHEDULE 13D/AAmendment 2	Open filing 0001104659-26-076580 Dispute this row
PHILIP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share	20.1	7,558,665.00	04/20/2026 Filed 2026-04-22	SCHEDULE 13D/AAmendment 1	Open filing 0001104659-26-046494 Dispute this row
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share	20.1	7,558,665.00	04/20/2026 Filed 2026-04-22	SCHEDULE 13D/AAmendment 1	Open filing 0001104659-26-046494 Dispute this row
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share	20.1	7,558,665.00	04/20/2026 Filed 2026-04-22	SCHEDULE 13D/AAmendment 1	Open filing 0001104659-26-046494 Dispute this row
PHILP DANIELE BARACH FAMILY TRUST Class A Common Stock, Par Value $0.0001 Per Share	9.56	3,012,048.00	12/19/2025 Filed 2026-04-03	SCHEDULE 13D	Open filing 0001104659-26-039490 Dispute this row
PHILIP A. BARACH Class A Common Stock, Par Value $0.0001 Per Share	9.56	3,012,048.00	12/19/2025 Filed 2026-04-03	SCHEDULE 13D	Open filing 0001104659-26-039490 Dispute this row
DANIELE BARACH Class A Common Stock, Par Value $0.0001 Per Share	9.56	3,012,048.00	12/19/2025 Filed 2026-04-03	SCHEDULE 13D	Open filing 0001104659-26-039490 Dispute this row
Dragasac Limited Class A Common Stock, par value $0.0001 per share	23.8	6,335,630	07/24/2025 Filed 2025-07-28	SCHEDULE 13D/AAmendment 6	Open filing 0000905148-25-002573 Dispute this row
Resorts World Inc Pte. Ltd. Class A Common Stock, par value $0.0001 per share	13.3	4,100,000	07/24/2025 Filed 2025-07-28	SCHEDULE 13D/AAmendment 6	Open filing 0000905148-25-002573 Dispute this row
Genting Berhad Class A Common Stock, par value $0.0001 per share	33.9	10,435,630	07/24/2025 Filed 2025-07-28	SCHEDULE 13D/AAmendment 6	Open filing 0000905148-25-002573 Dispute this row
Lim Kok Thay Class A Common Stock, par value $0.0001 per share	41	14,138,161	07/24/2025 Filed 2025-07-28	SCHEDULE 13D/AAmendment 6	Open filing 0000905148-25-002573 Dispute this row
Lincoln Alternative Strategies LLC Class A Common Stock, $0.0001 par value per share	0	0.00	07/14/2025 Filed 2026-02-11	SCHEDULE 13G/AAmendment 1	Open filing 0001493152-26-006196 Dispute this row
Lincoln Alternative Strategies LLC Class A Common Stock, $0.0001 par value per share	5.14	1,230,769.00	07/14/2025 Filed 2025-08-27	SCHEDULE 13G	Open filing 0001641172-25-025647 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

1,970,197 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing year	Filings read
2015	1
2016	204,322
2017	202,494
2018	202,048
2019	193,638
2020	144,184
2021	224,474
2022	40,015
2023	199,811
2024	84,357
2025	235,520
2026	233,555

Filings made before the SEC required XML are listed, not extracted.

Back to Celularity Inc